Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

CLL and breast cancer differ in the expression of regulatory microRNAs

Key clinical point: Chronic lymphocytic leukemia and breast cancer microRNAs show diagnostic and prognostic potential.

Major finding: Studied microRNA expression in breast cancer and chronic lymphocytic leukemia patients was significantly higher than in healthy controls (P less than .001).

Study details: A molecular analysis of blood from 15 chronic lymphocytic leukemia patients and tissue samples from 15 breast cancer patients.

Disclosures: The authors reported that they had no competing interests.

Citation:

Raeisi F et al. Mol Ther Oncolytics. 2020;16:230-7.